Top Research Reports for Alphabet, Johnson & Johnson & Union Pacific
Alphabet shares have modestly outperformed the Zacks Internet Services industry in the year to date period (+23.7% vs. +22.2%), with most of the gains coming after the search giant's impressive Q3 results. Additionally, strong focus on innovation of AI techniques and the home automation space should aid business growth in the long term. However, the company’s growing litigation issues and increasing expenses might hurt profitability. Shares of Johnson & Johnson have gained +7.4% over the past year against the Zacks Large Cap Pharmaceuticals industry’s rise of +0.4%. The Zacks analyst believes that the Pharma unit is performing at above-market levels, supported by successful label expansion of blockbuster drugs, Imbruvica, Darzalex and Stelara.